Hillsdale Investment Management Inc. Puma Biotechnology, Inc. Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$2.63 - $4.09 $2.04 Million - $3.17 Million	-775,627 Reduced 96.6%	27,276 $71,000
Q2 2023 Aug 11, 2023	SELL	$2.6 - $3.58 $81,120 - $111,696	-31,200 Reduced 3.74%	802,903 $2.83 Million
Q1 2023 May 10, 2023	BUY	$2.21 - $4.82 $371,052 - $809,263	167,897 Added 25.2%	834,103 $2.58 Million
Q4 2022 Feb 13, 2023	BUY	$2.12 - $5.08 $1.41 Million - $3.38 Million	666,206 New	666,206 $2.82 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $128M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.